Becton Dickinson

Becton, Dickinson and Company (BD) announced a $23 million expansion of its complex in Juncos, Puerto Rico, including $16 million from BD for equipment, construction, and job creation, and $7 million in incentives from the DDEC. The expansion will increase production capacity.

Becton Dickinson (BD) announced the start of operations of its new manufacturing plant in Hermosillo, Sonora, Mexico. The company invested US$9 million and expects to generate around 1,400 direct jobs producing medical devices.

Metro North Hospital & Health Service awarded a contract to Becton Dickinson Pty Ltd for indirect supplies, valued at AUD 2,155,243.60.

Becton Dickinson received additional orders from the US and Canadian governments for 177 million syringes and needles for COVID-19 vaccination programs, with distribution starting by end of December 2020.

Becton Dickinson was awarded nearly $23.7 million by the U.S. Defense Department for medical surgical products. The contract has a one-year base with nine one-year option periods and a performance completion date of September 28, 2020.

DHL Supply Chain, acting on behalf of NHS Supply Chain, awarded Becton, Dickinson UK Ltd a non-exclusive framework agreement for intravenous cannulae and associated products valued at GBP 136,000,000. The contract was published on 2019-05-16.

Becton Dickinson (BD) is building a £2.5 million factory extension at its Plymouth plant, part of a £100 million investment creating 100 jobs, to increase production of Vacutainer blood collection tubes.

Becton Dickinson is completing a 5,000-square-meter expansion of its plant in Fraga, Spain, which manufactures syringes, hypodermic needles, and prefilled syringes. The plant employs over 600 people and produces over 6 billion units annually.

DHL Supply Chain was awarded a contract by Becton Dickinson (BD) to handle warehousing and distribution for select sites in India. The project includes a new temperature-controlled site in Luhari, Haryana, and is scheduled for completion by mid-2019.

NHS Supply Chain awarded a £144m framework agreement to Becton, Dickinson U.K. Ltd for the supply of needlefree connection systems and associated products.

Becton Dickinson (BD) is doubling production capacity at its Cuautitlán, Mexico plant by adding new machinery, increasing output from 20 million to 40 million units per year of prepared and dehydrated culture media. The expansion will also increase dehydrated culture production from 32 to 70 tonnes per year.

Becton Dickinson has agreed to invest up to $150 million into its Sumter, South Carolina facilities, adding 125 jobs. The investment was approved by the Sumter County Council.

Apax Funds signed a definitive agreement to acquire Becton Dickinson's 49.9% minority stake in Vyaire Medical for $435 million. The transaction is expected to close in April 2018.

CareFusion Solutions, a Becton Dickinson subsidiary, won a five-year, $49.5 million firm-fixed-price contract from the U.S. Defense Department for medical equipment, awarded after bids from 31 suitors and good through Dec. 20, 2022.

BD (Becton, Dickinson and Company) announced a definitive agreement to acquire C. R. Bard, Inc. for $317.00 per share in cash and stock, total consideration $24 billion. The transaction is expected to be immediately accretive and generate cost synergies.

Becton Dickinson & Co. (BD) won a $100 million contract from the U.S. Department of Defense to provide its Pyxis ES medication dispensing technology to 115 military inpatient health facilities and pharmacies across the U.S., Asia, and Europe.

Becton Dickinson plans to shut down its Creedmoor, North Carolina manufacturing facility, laying off about 120 workers. Production will move to existing facilities in Mexico and Utah.

US medical technology company Becton Dickinson is investing 34 billion forints (EUR 110m) to expand its syringe plant in Tatabánya, Hungary. The investment will create 219 jobs and is supported by a 2.7 billion forint government grant. Construction is expected to start within 8-10 months and be completed within three years.